Common asthma drug improves strength in children with muscle disease
News-Medical reports a small, single-centre, open-label crossover trial from the University of Gothenburg in which 18 children and young people aged 6–16 with congenital myopathy took oral salbutamol, an asthma drug, for 24 weeks alongside usual care. Motor function scores averaged 3.61 points higher and grip strength rose approximately 1.5 kilograms versus usual care alone. Researchers say larger, longer studies are needed.
Why it matters: Relevant to pediatric neurologists, rehabilitation clinicians and Maryland families following research on rare inherited muscle diseases that begin in childhood.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to news-medical.net. October 14, 2026.
